{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:03:54Z","timestamp":1788473034737,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.transci.2020.102993","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T18:13:38Z","timestamp":1604340818000},"page":"102993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy"],"prefix":"10.1016","volume":"59","author":[{"given":"Sahar","family":"Balagholi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasul","family":"Dabbaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyman","family":"Eshghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Asadollah","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Heshmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2020.102993_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2020.03.019","article-title":"Coronavirus disease 2019 (COVID-19): a literature review","author":"Harapan","year":"2020","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.transci.2020.102993_bib0010","article-title":"Application of plasmapheresis for Covid-19 patients","author":"Turgutkaya","year":"2020","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2020.102993_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by novel coro-navirus from Wuhan: an analysis based on decade-long structural studies of SARS","author":"Wan","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.transci.2020.102993_bib0020","first-page":"1","article-title":"Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment","author":"Soy","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"10223","key":"10.1016\/j.transci.2020.102993_bib0025","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.transci.2020.102993_bib0030","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of theCytokine Storm\u2019in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.transci.2020.102993_bib0035","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.coviro.2012.04.004","article-title":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon","volume":"2","author":"Totura","year":"2012","journal-title":"Curr Opin Virol"},{"issue":"2","key":"10.1016\/j.transci.2020.102993_bib0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.transci.2020.102993_bib0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.transci.2020.102993_bib0050","series-title":"Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease","author":"Golonka","year":"2020"},{"key":"10.1016\/j.transci.2020.102993_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.06.017","article-title":"Cytokine storms: understanding COVID-19","author":"Mangalmurti","year":"2020","journal-title":"Immunity"},{"issue":"10223","key":"10.1016\/j.transci.2020.102993_bib0060","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2020.102993_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108408","article-title":"Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19","volume":"214","author":"Ma","year":"2020","journal-title":"Clin Immunol"},{"issue":"11","key":"10.1016\/j.transci.2020.102993_bib0070","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2020.102993_bib0075","article-title":"The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure","volume":"8","author":"Keith","year":"2020","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.transci.2020.102993_bib0080","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis","author":"Lippi","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.transci.2020.102993_bib0085","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619887437","article-title":"Acute respiratory distress syndrome as an organ phenotype of vascular microthrombotic disease: based on hemostatic theory and endothelial molecular pathogenesis","volume":"25","author":"Chang","year":"2019","journal-title":"Clin Appl Thromb"},{"issue":"6","key":"10.1016\/j.transci.2020.102993_bib0090","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/SHK.0000000000000341","article-title":"ADAMTS-13 in critically ill patients with septic syndromes and noninfectious systemic inflammatory response syndrome","volume":"43","author":"Aibar","year":"2015","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.transci.2020.102993_bib0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3324\/haematol.11677","article-title":"Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor","volume":"93","author":"Bockmeyer","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2020.102993_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.transci.2020.102993_bib0105","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.transci.2020.102993_bib0110","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2020.102993_bib0115","first-page":"E009-","article-title":"A pathological report of three COVID-19 cases by minimally invasive autopsies","volume":"49","author":"Yao","year":"2020","journal-title":"Zhonghua bing li xue za zhi= Chin J Pathol"},{"issue":"1","key":"10.1016\/j.transci.2020.102993_bib0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13613-019-0530-y","article-title":"Cytokine removal in human septic shock: where are we and where are we going?","volume":"9","author":"Honore","year":"2019","journal-title":"Ann Intensive Care"},{"issue":"3","key":"10.1016\/j.transci.2020.102993_bib0125","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"issue":"5","key":"10.1016\/j.transci.2020.102993_bib0130","article-title":"Removal of Endotoxin and cytokine by plasmapheresis filtration with plasa exchange therapy (TPE) could benefit patient with COVID-19 in critical condition","volume":"10","year":"2020","journal-title":"J Anesth Intens Care Med"},{"issue":"10229","key":"10.1016\/j.transci.2020.102993_bib0135","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"10","key":"10.1016\/j.transci.2020.102993_bib0140","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00134-002-1410-7","article-title":"Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial","volume":"28","author":"Busund","year":"2002","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.transci.2020.102993_bib0145","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1186\/s13054-014-0699-2","article-title":"The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis","volume":"18","author":"Rimmer","year":"2014","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.transci.2020.102993_bib0150","doi-asserted-by":"crossref","first-page":"e858","DOI":"10.1097\/CCM.0000000000002362","article-title":"Effects of polymyxin B hemoperfusion on mortality in patients with severe sepsis and septic shock: a systemic review, meta-analysis update, and disease severity subgroup meta-analysis","volume":"45","author":"Chang","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1016\/j.transci.2020.102993_bib0155","first-page":"1","article-title":"Can plasmapheresis be useful in the treatment of patients with Covid-19?","author":"Bolaman","year":"2020","journal-title":"Asian Hematol Res J"},{"issue":"5","key":"10.1016\/j.transci.2020.102993_bib0160","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3892\/etm.2015.2340","article-title":"Prediction of a sustained viral response in chronic hepatitis C patients who undergo induction therapy with double filtration plasmapheresis plus interferon-\u03b2\/ribavirin","volume":"9","author":"Ishikawa","year":"2015","journal-title":"Exp Ther Med"},{"issue":"5","key":"10.1016\/j.transci.2020.102993_bib0165","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4103\/ijn.IJN_64_17","article-title":"Effect of double filtration plasmapheresis on various plasma components and patient safety: a Prospective observational cohort study","volume":"27","author":"Jagdish","year":"2017","journal-title":"Indian J Nephrol"},{"issue":"2","key":"10.1016\/j.transci.2020.102993_bib0170","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/1744-9987.12240","article-title":"Evaluation of plasma exchange and continuous veno\u2010venous hemofiltration for the treatment of severe avian influenza a (H7N9): a cohort study","volume":"19","author":"Liu","year":"2015","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2020.102993_bib0175","article-title":"A promising anti-cytokine-storm targeted therapy for COVID-19: the artificial-liver blood-purification system","author":"Zhang","year":"2020","journal-title":"Engineering (Beijing)"},{"issue":"2","key":"10.1016\/j.transci.2020.102993_bib0180","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PCC.0b013e3181e2a569","article-title":"Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A\u2014an associated respiratory failure and hemodynamic shock","volume":"12","author":"Patel","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.transci.2020.102993_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.transci.2020.102993_bib0190","series-title":"A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19","author":"Keith","year":"2020"},{"issue":"9","key":"10.1016\/j.transci.2020.102993_bib0195","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/0885066620940259","article-title":"Therapeutic plasma exchange: a potential management strategy for critically ill COVID-19 patients","volume":"35","author":"Tabibi","year":"2020","journal-title":"J Intensive Care Med"},{"issue":"1","key":"10.1016\/j.transci.2020.102993_bib0200","article-title":"Clinical observation of 6 severe COVID-19 patients treated with plasma exchange or tocilizumab","volume":"49","author":"Luo","year":"2020","journal-title":"J Zhejiang Univ (Med Sci)"},{"issue":"2","key":"10.1016\/j.transci.2020.102993_bib0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105974","article-title":"Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19","volume":"56","author":"Shi","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.transci.2020.102993_bib0210","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijid.2020.06.064","article-title":"Therapeutic plasma exchange in adults with severe COVID-19 infection","volume":"99","author":"Khamis","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.transci.2020.102993_bib0215","article-title":"Expert recommendations on blood purification treatment protocol for patients with severe COVID-19: recommendation and consensus","author":"Yang","year":"2020","journal-title":"Chronic Dis Transl Med"},{"issue":"10223","key":"10.1016\/j.transci.2020.102993_bib0220","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.transci.2020.102993_bib0225","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jca.20303","article-title":"Therapeutic apheresis: a review of complications and recommendations for prevention and management","volume":"26","author":"Mokrzycki","year":"2011","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2020.102993_bib0230","first-page":"1","article-title":"Efficacy of plasmapheresis and immunoglobulin replacement therapy (IVIG) on patients with COVID-19","author":"Pourahmad","year":"2020","journal-title":"SN Comprehens Clin Med"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050220303153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050220303153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:52:18Z","timestamp":1761468738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050220303153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1473050220303153"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2020.102993","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2020.102993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102993"}}